1. Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke
- Author
-
Honegger, Tim, Schweizer, Juliane, Bicvic, Antonela, Westphal, Laura P, Schütz, Valerie, Inauen, Corinne, Pokorny, Thomas, Bracher, Katja, Arnold, Marcel, Fischer, Urs, Bonati, Leo H, De Marchis, Gian Marco, Nedeltchev, Krassen, Kahles, Timo, Cereda, Carlo, Kägi, Georg, Montaner, Joan, Bustamante, Alejandro, Palà, Elena, Ntaios, George, Foerch, Christian, Luft, Andreas, Spanaus, Katharina, Saleh, Lanja, von Eckardstein, Arnold, Arnold, Markus, Katan, Mira, Universitat Autònoma de Barcelona, Institut Català de la Salut, [Honegger T, Schweizer J, Westphal LP, Schütz V, Inauen C] Department of Neurology, University Hospital Zurich, Zurich, Switzerland. [Bicvic A] Department of Neurology, Inselspital University of Berne, Switzerland. [Montaner J] Grup de Recerca de Malalties Neurovasculars, Vall d’Hebron Institut de Recerca (VHIR) Barcelona, Spain. Institute de Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocío/CSIC/University of Seville. Department of Neurology, Hospital Universitario Virgen Macarena, Seville. [Palà E] Grup de Recerca de Malalties Neurovasculars, Vall d’Hebron Institut de Recerca (VHIR) Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Ischemic stroke ,Sèrum ,Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders [DISEASES] ,enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares [ENFERMEDADES] ,610 Medicine & health ,Intracranial hemorrhage ,Serum biomarker ,Nervous System Diseases::Central Nervous System Diseases::Brain Diseases::Cerebrovascular Disorders::Intracranial Hemorrhages::Cerebral Hemorrhage [DISEASES] ,Biological Factors::Biomarkers [CHEMICALS AND DRUGS] ,enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades cerebrales::trastornos cerebrovasculares::hemorragias intracraneales::hemorragia cerebral [ENFERMEDADES] ,factores biológicos::biomarcadores [COMPUESTOS QUÍMICOS Y DROGAS] ,Stroke complications ,Fluids and Secretions::Body Fluids::Blood::Serum [ANATOMY] ,Edema cerebral - Diagnòstic ,Brain edema ,Marcadors bioquímics ,570 Life sciences ,biology ,líquidos y secreciones::líquidos corporales::sangre::suero [ANATOMÍA] ,Hemorràgia cerebral - Diagnòstic ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,S-100B - Abstract
Brain edema; Intracranial hemorrhage; Serum biomarker Edema cerebral; Hemorragia intracraneal; Biomarcador sérico Edema cerebral; Hemorràgia intracranial; Biomarcador sèric Background: Early identification of patients developing symptomatic intracranial hemorrhage and symptomatic brain edema after acute ischemic stroke is essential for clinical decision-making. Astroglial protein S-100B is a marker of blood-brain barrier disruption, which plays an important role in the formation of intracranial hemorrhage and brain edema. In this study, we assessed the prognostic value of serum S-100B for the development of these complications. Methods: Serum S-100B levels were measured within 24 h from symptom onset in 1749 consecutive acute ischemic stroke patients from the prospective, observational, multicenter BIOSIGNAL cohort study (mean age 72.0 years, 58.3% male). To determine symptomatic intracranial hemorrhage or symptomatic brain edema, follow-up neuroimaging was performed in all patients receiving reperfusion therapy or experiencing clinical worsening with an NIHSS increase of ⩾4. Results: Forty six patients (2.6%) developed symptomatic intracranial hemorrhage and 90 patients (5.2%) developed symptomatic brain edema. After adjustment for established risk factors, log10S-100B levels remained independently associated with both symptomatic intracranial hemorrhage (OR 3.41, 95% CI 1.7–6.9, p = 0.001) and symptomatic brain edema (OR 4.08, 95% CI 2.3–7.1, p
- Published
- 2022